Tobacco plants used to develop new rabies treatment

02/3/2013 | News-Medical.Net

In an attempt to create a more cost-effective treatment for people in impoverished countries who are infected with the rabies virus, researchers in London developed a monoclonal antibody to rabies using leaves of the tobacco plant. The antibody blocks the virus from adhering to nerve endings at the site of the initial bite. "An untreated rabies infection is nearly 100% fatal and is usually seen as a death sentence. Producing an inexpensive antibody in transgenic plants opens the prospect of adequate rabies prevention for low-income families in developing countries," said researcher Leonard Both.

View Full Article in:

News-Medical.Net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN